Festival of Biologics San Diego

Brochure download

information we require

please check before submitting



Privacy statement »

Manage your email preferences »

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

OUR STORY

 

The Inaugural Festival of Biologics San Diego combines four, outstanding conferences, focusing on antibodies, immunotherapy, clinical trials and biosimilar, all under one roof.   
 
The Festival of Biologics San Diego was born out of our successful European event, the Festival Of Biologics Basel, which consists of 5 world leading events: The European Antibody Congress, the World Immunotherapy Congress, Clinical Trials 2018, The World Biosimilar Congress and HPAPI World Congress. Having run very successfully in Basel, Switzerland for the past three years, and across other European countries for the past 13 years, we thought it was time to bring our event across the pond to the US, where biologics research and development is fast growing and innovative.
 
Our flagship conference, the European Antibody Congress first graced the stages of Lyon in 2004. Our first event consisted of just 40 speakers and 100 attendees. Between 2004 and 2018 the congress has grown from strength to strength, moving from Lyon, to Geneva and settling in our Basel home in 2015. Over the years we’ve added additional long running events – the World Biosimilar Congress (est. 2012 in London), the HPAPI World Congress (est. 2013 in Munich), the World Immunotherapy Congress (est. 2016 in Basel), and our newest addition Clinical Trials 2018 (est. 2018 in Basel). The Festival of Biologics Basel 2018 is expected to bring 1000+ delegates, 300+ speakers and 80+ sponsors and exhibitors.
 
Biologics are transforming the lives of patients across the globe, and are poised to become even more important in upcoming years. In 2013 it was estimated that biologics provided close to 22% of global pharmaceutical sales, with the expectation for it to rise to 32% in 2023 (The Economist, 2013). Biologic sales are dominated by the US, with a market share of 43%. With massive biologic players such as AbbVie, Amgen and Genentech based in the US, and with over 15,000 individuals working within the biologics sphere in San Diego, the Festival of Biologics San Diego will have great global and local reach.
 
With high level, global speakers from big pharma, biotech, academia and industry, the Festival of Biologics San Diego will address the strategic and commercial aspects of discovering, developing, and bringing new biologics to patients. We bring you two days packed full of top level science, data and case studies, workshops, roundtables and networking opportunities. With 200+ speakers, 80 sponsors and exhibitors and hundreds of companies in attendance, this is not an event to be missed.
 
The Festival of Biologics San Diego will bring together four high level, commercial events: The Americas Antibody Congress, the World Immunotherapy Congress USA, Clinical Trials America and the World Biosimilar Congress USA.